Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 75 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 8357379

    High concentration baclofen preparations

    The Board of Regents of the University of Texas System · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  2. US 8354240

    VMP-like sequences of pathogenic Borrelia

    The Board of Regents of the University of Texas System · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  3. US 8354450

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  4. US 8343506

    Chimeric chikungunya virus and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  5. US 8343481

    Method of preparing lung alveolar epithelial type II cells derived from embryonic stem cells

    The Board of Regents of the University of Texas System · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  6. US 8338366

    Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

    The Board of Regents of the University of Texas System · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  7. US 8333959

    Ex-vivo application of solid microparticulate therapeutic agents

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  8. US 8334259

    Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative

    The Board of Regents of the University of Texas System · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  9. US 8334239

    High affinity VEGF-receptor antagonists

    The Board of Regents of the University of Texas System · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  10. US 8329141

    Locoregional internal radionuclide ablation of abnormal tissues

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  11. US 8328785

    Use of nanoparticles in the photodynamic treatment of tumors

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  12. US 8329745

    Small molecule inhibitors of ghrelin O-acyltransferase

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  13. US 8323962

    Molecules with extended half-lives, compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  14. US 8324181

    Modulation of gene expression by oligomers targeted to chromosomal DNA

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  15. US 8323906

    Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  16. US 8323665

    Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  17. US 8318951

    Stem cell differentiating agents and uses therefor

    The Board of Regents of the University of Texas System · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  18. US 8309595

    Hydrazone modulators of cannabinoid receptors

    The Board of Regents of the University of Texas System · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted

  19. US 8304247

    Recognitive hydrogel

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  20. US 8304397

    Identification of a micro-RNA that activates expression of β-myosin heavy chain

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  21. US 8303995

    Nitrite formulations and their use as nitric oxide prodrugs

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  22. US 8304526

    Antitumor effect of mutant Bik

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  23. US 8304399

    Hedgehog signaling pathway proteins and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  24. US 8299033

    Iodo-hexose compounds useful to treat cancer

    The Board of Regents of the University of Texas System · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.